Duprey Lauren Rusckowski
SEC insider (Form 3/4/5 filer). CIK 0001977746. Chief Transformation Officer at TAKEDA PHARMACEUTICAL CO LTD (TAK). 4 reported Form 4/5 transactions since Sep 2024; latest on Sep 14, 2026. Located in LEXINGTON, MA.
Companies Duprey Lauren Rusckowski has filed insider reports for
- TAKEDA PHARMACEUTICAL CO LTD (TAK): Officer, Chief Transformation Officer
Duprey Lauren Rusckowski
CIK: 0001977746
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TAK
TAKEDA PHARMACEUTICAL CO LTD
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 14, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
SaleDirect34.5K shares at avg. $18.54$640K - Aug 10, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
SaleDirect47.6K shares at avg. $17.10$814K - Jul 1, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
AwardDirect45.1K shares- - Apr 27, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
AwardDirect60K shares-
1-4 of 4 transactions